Optimal doses of caspofungin during continuous venovenous hemodiafiltration in critically ill patients

被引:11
|
作者
Aguilar, Gerardo [1 ]
Ferriols, Rafael [2 ]
Lozano, Angels [1 ]
Ezquer, Carlos [3 ]
Carbonell, Jose A. [1 ]
Jurado, Ana [1 ]
Carrizo, Juan [1 ]
Serralta, Ferran [1 ]
Puig, Jaume [1 ]
Navarro, David [4 ,5 ]
Alos, Manuel [2 ]
Javier Belda, F. [1 ,5 ]
机构
[1] Univ Valencia, Hosp Clin, Surg Intens Care Unit, Dept Anesthesiol & Intens Care, Ave Blasco Ibanez 17, Valencia 46010, Spain
[2] Univ Valencia, Hosp Clin, Dept Pharm, Ave Blasco Ibanez 17, Valencia 46010, Spain
[3] INCLIVA, Inst Invest Sanitaria, Ave Blasco Ibanez 17, Valencia 46010, Spain
[4] Univ Valencia, Hosp Clin, Dept Microbiol, Ave Blasco Ibanez 17, Valencia 46010, Spain
[5] Univ Valencia, Sch Med, Ave Blasco Ibanez 17, Valencia 46010, Spain
来源
CRITICAL CARE | 2017年 / 21卷
关键词
Echinocandins; Continuous renal replacement therapy; Invasive candidiasis; RENAL REPLACEMENT THERAPY; PHARMACOKINETICS;
D O I
10.1186/s13054-016-1594-9
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [21] Continuous venovenous hemofiltration versus continuous venovenous hemodiafiltration in critically ill patients: A retrospective cohort study from a Canadian tertiary centre
    AlEnezi, Farhan
    Alhazzani, Waleed
    Ma, Jinhui
    Alanazi, Safug
    Salib, Mary
    Attia, Menat
    Thabane, Lehana
    Fox-Robichaud, Alison
    CANADIAN RESPIRATORY JOURNAL, 2014, 21 (03) : 176 - 180
  • [22] ACUTE-RENAL-FAILURE IN THE CRITICALLY ILL - MANAGEMENT BY CONTINUOUS VENOVENOUS HEMODIAFILTRATION
    BELLOMO, R
    PARKIN, G
    BOYCE, N
    JOURNAL OF CRITICAL CARE, 1993, 8 (03) : 140 - 144
  • [23] Clearance of ceftazidime during continuous venovenous haemofiltration in critically ill patients
    Traunmüller, F
    Schenk, P
    Mittermeyer, C
    Thalhammer-Scherrer, R
    Ratheiser, K
    Thalhammer, F
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 49 (01) : 129 - 134
  • [24] Pharmacokinetics and the optimal regimen for levofloxacin in critically ill patients receiving continuous hemodiafiltration
    Takeshi Wada
    Masaki Kobayashi
    Yuichi Ono
    Asumi Mizugaki
    Kenichi Katabami
    Kunihiko Maekawa
    Daisuke Miyamoto
    Yuichiro Yanagida
    Mineji Hayakawa
    Atsushi Sawamura
    Ken Iseki
    Satoshi Gando
    Journal of Intensive Care, 3 (1)
  • [25] Pharmacokinetics and the optimal regimen for levofloxacin in critically ill patients receiving continuous hemodiafiltration
    Wada, Takeshi
    Kobayashi, Masaki
    Ono, Yuichi
    Mizugaki, Asumi
    Katabami, Kenichi
    Maekawa, Kunihiko
    Miyamoto, Daisuke
    Yanagida, Yuichiro
    Hayakawa, Mineji
    Sawamura, Atsushi
    Iseki, Ken
    Gando, Satoshi
    JOURNAL OF INTENSIVE CARE, 2015, 3
  • [26] Vancomycin clearance during continuous venovenous haemofiltration in critically ill patients
    Chaijamorn, Weerachai
    Jitsurong, Arnurai
    Wiwattanawongsa, Kamonthip
    Wanakamanee, Usanee
    Dandecha, Phongsak
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2011, 38 (02) : 152 - 156
  • [27] Vancomycin clearance during continuous venovenous haemofiltration in critically ill patients
    F. T. J. Boereboom
    F. F. T. Ververs
    P. J. Blankestijn
    T. J. F. Savelkoul
    A. van Dijk
    Intensive Care Medicine, 1999, 25 : 1100 - 1104
  • [28] Vancomycin clearance during continuous venovenous haemofiltration in critically ill patients
    Boereboom, FTJ
    Ververs, FFT
    Blankestijn, PJ
    Savelkoul, TJF
    van Dijk, A
    INTENSIVE CARE MEDICINE, 1999, 25 (10) : 1100 - 1104
  • [29] Population pharmacokinetic/pharmacodynamic evaluations of amikacin dosing in critically ill patients undergoing continuous venovenous hemodiafiltration
    Li, Sanwang
    Zhu, Sucui
    Xie, Feifan
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2023, 75 (04) : 515 - 522
  • [30] Pharmacokinetics of colistin methanesulfonate and colistin in a critically ill patient receiving continuous venovenous hemodiafiltration
    Li, J
    Rayner, CR
    Nation, RL
    Deans, R
    Boots, R
    Widdecombe, N
    Douglas, A
    Lipman, J
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (11) : 4814 - 4815